Search research articles
Contact Us
Filters
Showing results (71-80 of 156) with videos related to
Page
of 16
Sort By:
Current Psychiatry Reports
|
May 19, 2015
Children's disaster reactions: the influence of family and social factors
Betty Pfefferbaum, Anne K Jacobs, J Brian Houston, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 22, 2005
Prediction of metabolic clearance using cryopreserved human hepatocytes: kinetic characteristics for five benzodiazepines
David Hallifax, Helen C Rawden, Nancy Hakooz, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 18, 2005
Impact of parallel pathways of drug elimination and multiple cytochrome P450 involvement on drug-drug interactions: CYP2D6 paradigm
Kiyomi Ito, David Hallifax, R Scott Obach, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)
|
May 20, 2016
Ramp Study Hemodynamics, Functional Capacity, and Outcome in Heart Failure Patients with Continuous-Flow Left Ventricular Assist Devices
Mette H Jung, Finn Gustafsson, Brian Houston, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
April 16, 2008
Hepatocellular binding of drugs: correction for unbound fraction in hepatocyte incubations using microsomal binding or drug lipophilicity data
Peter J Kilford, Michael Gertz, J Brian Houston, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
January 11, 2013
Application of a physiologically based pharmacokinetic model to assess propofol hepatic and renal glucuronidation in isolation: utility of in vitro and in vivo data
Katherine L Gill, Michael Gertz, J Brian Houston, et al.
British Journal of Clinical Pharmacology
|
October 21, 2005
Prediction of in vivo drug-drug interactions from in vitro data: impact of incorporating parallel pathways of drug elimination and inhibitor absorption rate constant
Hayley S Brown, Kiyomi Ito, Aleksandra Galetin, et al.
Clinical Pharmacokinetics
|
September 21, 2006
Prediction of in vivo drug-drug interactions from in vitro data : factors affecting prototypic drug-drug interactions involving CYP2C9, CYP2D6 and CYP3A4
Hayley S Brown, Aleksandra Galetin, David Hallifax, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 3, 2004
Utility of recombinant enzyme kinetics in prediction of human clearance: impact of variability, CYP3A5, and CYP2C19 on CYP3A4 probe substrates
Aleksandra Galetin, Caroline Brown, David Hallifax, et al.
The Prevention Researcher
|
December 3, 2009
Youth's Reactions to Disasters and the Factors That Influence Their Response
Betty Pfefferbaum, J Brian Houston, Carol S North, et al.
Page
of 16
Search research articles
Search
Showing results (71-80 of 156) with videos related to
Sort By:
Page
of 16
Current Psychiatry Reports
|
May 19, 2015
Children's disaster reactions: the influence of family and social factors
Betty Pfefferbaum, Anne K Jacobs, J Brian Houston, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 22, 2005
Prediction of metabolic clearance using cryopreserved human hepatocytes: kinetic characteristics for five benzodiazepines
David Hallifax, Helen C Rawden, Nancy Hakooz, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 18, 2005
Impact of parallel pathways of drug elimination and multiple cytochrome P450 involvement on drug-drug interactions: CYP2D6 paradigm
Kiyomi Ito, David Hallifax, R Scott Obach, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)
|
May 20, 2016
Ramp Study Hemodynamics, Functional Capacity, and Outcome in Heart Failure Patients with Continuous-Flow Left Ventricular Assist Devices
Mette H Jung, Finn Gustafsson, Brian Houston, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
April 16, 2008
Hepatocellular binding of drugs: correction for unbound fraction in hepatocyte incubations using microsomal binding or drug lipophilicity data
Peter J Kilford, Michael Gertz, J Brian Houston, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
January 11, 2013
Application of a physiologically based pharmacokinetic model to assess propofol hepatic and renal glucuronidation in isolation: utility of in vitro and in vivo data
Katherine L Gill, Michael Gertz, J Brian Houston, et al.
British Journal of Clinical Pharmacology
|
October 21, 2005
Prediction of in vivo drug-drug interactions from in vitro data: impact of incorporating parallel pathways of drug elimination and inhibitor absorption rate constant
Hayley S Brown, Kiyomi Ito, Aleksandra Galetin, et al.
Clinical Pharmacokinetics
|
September 21, 2006
Prediction of in vivo drug-drug interactions from in vitro data : factors affecting prototypic drug-drug interactions involving CYP2C9, CYP2D6 and CYP3A4
Hayley S Brown, Aleksandra Galetin, David Hallifax, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 3, 2004
Utility of recombinant enzyme kinetics in prediction of human clearance: impact of variability, CYP3A5, and CYP2C19 on CYP3A4 probe substrates
Aleksandra Galetin, Caroline Brown, David Hallifax, et al.
The Prevention Researcher
|
December 3, 2009
Youth's Reactions to Disasters and the Factors That Influence Their Response
Betty Pfefferbaum, J Brian Houston, Carol S North, et al.
Page
of 16